Yongan Pharmaceutical to Expand Taurine Project - ECONOMY AND BUSINESS

Jul.21.2020

Hengli Nantong Phase III Project Under Construction

Jul.21.2020

Jiangxi and Shaanxi Provinces Sign Energy Strategic Cooperation Contract

Jul.21.2020

Hazardous Chemical Enterprises in Five Cases Will Be Shut down

Jul.21.2020

China’s Foreign Exchange Reserves Reach US$3.11 Trillion at the End of June

Jul.21.2020

China Propels Special Rectification Action on Production Safety

Jul.21.2020

BP and ENN Group Sign Natural Gas Purchase and Sales Agreement

Jul.21.2020

Brazil Extends Anti-dumping Measures on SAPP from China

Jul.16.2020

BASF Group: Operating Result In the Q2 of 2020 Above Market Expectations

Jul.06.2020

Kurt Bock Elected as New Chairman of the Supervisory Board of BASF SE

Jul.06.2020

Covestro CEO Leads European Plastics Association

Yongan Pharmaceutical to Expand Taurine Project

Year:2017 ISSUE:8
COLUMN:ECONOMY AND BUSINESS
Click:287 DateTime:May.09,2017

Yongan Pharmaceutical to Expand Taurine Project

QianjiangYongan Pharmaceutical Co., Ltd. on March 29 announced that it intends to invest RMB330million in expanding 30 000t/a Taurine project.
The company is located in Qianjiang city economic development area, Hubei province, which is engaged in Taurine business.